At the cellular level, it was demonstrated that tyrosinase activity in mouse melanoma B16 cells was significantly inhibited after the cells were treated with LFP at concentrations of 50 μg/mL and 100 μg/mL (without cytotoxicity) (p < 0.05 and 0.01). The gene discussed is TYR; the disease is melanoma.